EHHADH Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of EHHADH monoclonal antibodies for research focused on understanding EHHADH protein function. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). EHHADH, or enoyl-CoA hydratase and 3-hydroxyacyl-CoA dehydrogenase, functions as a crucial enzyme in fatty acid metabolism, with significant involvement in the β-oxidation pathway. EHHADH plays an essential role in breaking down long-chain fatty acids, which contributes to energy production and metabolic regulation. Research involving EHHADH has revealed important connections to various metabolic conditions and potential therapeutic approaches. Scientists studying EHHADH can explore its expression patterns across different tissues and cellular compartments. Investigating EHHADH activity provides valuable information about metabolic processes and energy homeostasis. Understanding EHHADH function continues to advance knowledge in metabolism research and disease mechanisms. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to make meaningful contributions to metabolic disease research and therapeutic development.